Additional file 2: Fig. S6B indicated that breast invasive carcinoma patients with CENPO mutation had poor prognosis in OS (p = 1.718e-3), but not DFS (p = 0.184), DSS (p = 0.722), and PFS (p = 372). This evidence concerns the gene CENPO and invasive breast carcinoma.